United States Últimas notícias

The Gorman-Rupp Company (NYSE:GRC) reported record third-quarter 2026 net sales of $193.3 million, up 11.8% year over year, as demand and pricing improved across its markets.

First Citizens BancShares (NASDAQ:FCNCA) reported third-quarter 2026 net income of $606 million, down 9.8% sequentially, while earnings per common share declined to $51.23.

First Citizens BancShares (NASDAQ:FCNCA) declared a quarterly common stock dividend of $2.25 per share, covering both Class A and Class B common shares.

Zymeworks (NASDAQ:ZYME) entered an exclusive global license and collaboration agreement with Roche for its experimental cancer treatment ZW209, with a $55 million upfront payment.

IDEAYA Biosciences (NASDAQ:IDYA) reported updated Phase 1 results for IDE849, showing a 60.8% confirmed objective response rate in second-line small cell lung cancer patients.

Flagstar Bank (NYSE:FLG) reported third-quarter 2026 net income attributable to common stockholders of $3 million, or $0.01 per diluted share, down from $26 million in the previous quarter.

SpaceX is reportedly in talks to secure a minimum of 80,000 cell sites across the US, a move that would solidify the rocket and satellite giant's path toward building a fourth nationwide wireless carrier. Ruhell Amin reports on Bloomberg Television.

Eni (NYSE:E) reported third-quarter 2026 adjusted net profit of €2.8 billion, more than doubling from a year earlier as higher production and a favorable commodity market supported earnings.

French authorities are bracing for a new round of protests Saturday. The military is preparing to back up police in a bid to prevent a repeat of last weekend's riots. Bloomberg's Alan Katz reports.

Phathom Pharmaceuticals (NASDAQ:PHAT) announced that BDR Pharmaceuticals International has filed a lawsuit against the U.S. Food and Drug Administration challenging regulatory exclusivity protections for VOQUEZNA tablets.

Veracyte (NASDAQ:VCYT) reported an analysis of Phase III STAMPEDE trial data suggesting its Decipher Prostate test may help identify patients who benefit from adding abiraterone to treatment.

Chemi Peres, the son of President Shimon Peres and Managing Partner and Co-Founder of Pitango says business is resilient and welcomes the end of war to scale up companies.